[DPHARMA] QoQ TTM Result on 31-Mar-2016 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Mar-2016 [#1]
Profit Trend
QoQ- -2.9%
YoY- 3.79%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 312,940 328,308 327,738 304,911 271,040 232,663 197,750 35.61%
PBT 31,479 42,709 46,824 47,508 49,765 46,157 45,813 -22.04%
Tax -4,653 -9,379 -11,087 -9,864 -10,980 -8,786 -8,393 -32.39%
NP 26,826 33,330 35,737 37,644 38,785 37,371 37,420 -19.81%
-
NP to SH 27,115 34,022 36,314 37,659 38,785 34,569 34,618 -14.96%
-
Tax Rate 14.78% 21.96% 23.68% 20.76% 22.06% 19.04% 18.32% -
Total Cost 286,114 294,978 292,001 267,267 232,255 195,292 160,330 46.86%
-
Net Worth 454,703 451,913 510,978 457,740 270,323 268,530 189,815 78.55%
Dividend
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Div 19,142 8,084 8,084 5,682 5,682 25,710 25,710 -17.77%
Div Payout % 70.60% 23.76% 22.26% 15.09% 14.65% 74.38% 74.27% -
Equity
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Net Worth 454,703 451,913 510,978 457,740 270,323 268,530 189,815 78.55%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 139,570 58.33%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 8.57% 10.15% 10.90% 12.35% 14.31% 16.06% 18.92% -
ROE 5.96% 7.53% 7.11% 8.23% 14.35% 12.87% 18.24% -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 112.18 117.69 102.62 109.24 162.43 139.50 141.68 -14.35%
EPS 9.72 12.20 11.37 13.49 23.24 20.73 24.80 -46.29%
DPS 6.86 2.90 2.53 2.04 3.41 15.42 18.50 -48.23%
NAPS 1.63 1.62 1.60 1.64 1.62 1.61 1.36 12.77%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 32.53 34.13 34.07 31.70 28.18 24.19 20.56 35.59%
EPS 2.82 3.54 3.78 3.91 4.03 3.59 3.60 -14.96%
DPS 1.99 0.84 0.84 0.59 0.59 2.67 2.67 -17.72%
NAPS 0.4727 0.4698 0.5312 0.4759 0.281 0.2792 0.1973 78.57%
Price Multiplier on Financial Quarter End Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 -
Price 1.98 2.06 2.04 2.55 2.62 2.72 2.65 -
P/RPS 1.76 1.75 1.99 2.33 1.61 1.95 1.87 -3.94%
P/EPS 20.37 16.89 17.94 18.90 11.27 13.12 10.68 53.49%
EY 4.91 5.92 5.57 5.29 8.87 7.62 9.36 -34.82%
DY 3.47 1.41 1.24 0.80 1.30 5.67 6.98 -37.11%
P/NAPS 1.21 1.27 1.28 1.55 1.62 1.69 1.95 -27.14%
Price Multiplier on Announcement Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 24/02/17 21/11/16 22/08/16 18/05/16 23/02/16 24/11/15 25/08/15 -
Price 2.23 2.10 2.14 2.40 2.61 2.70 2.40 -
P/RPS 1.99 1.78 2.09 2.20 1.61 1.94 1.69 11.45%
P/EPS 22.94 17.22 18.82 17.79 11.23 13.03 9.68 77.28%
EY 4.36 5.81 5.31 5.62 8.91 7.68 10.33 -43.58%
DY 3.08 1.38 1.18 0.85 1.30 5.71 7.71 -45.60%
P/NAPS 1.37 1.30 1.34 1.46 1.61 1.68 1.76 -15.31%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment